Article Details
Retrieved on: 2018-05-01 22:26:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>ARCH Venture Partners, Foresite Capital, a16z, GV and <b>Third Rock Ventures</b> are all on board. The investors have signed up in the belief that Koller can translate machine learning advances into biotech. In recent years, breakthroughs at Alphabet's DeepMind and elsewhere have reset expectations of ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here